Phase 1 study of intratumoral Pexa-Vec (JX-594), an oncolytic and immunotherapeutic vaccinia virus, in pediatric cancer patients.
about
Oncogenes: The Passport for Viral Oncolysis Through PKR InhibitionTargeted immunotherapy for pediatric solid tumorsOncolytic virotherapy for pediatric malignancies: future prospectsTrial Watch-Oncolytic viruses and cancer therapyPolymeric Cups for Cavitation-mediated Delivery of Oncolytic Vaccinia Virus.Deletion of F4L (ribonucleotide reductase) in vaccinia virus produces a selective oncolytic virus and promotes anti-tumor immunity with superior safety in bladder cancer models.Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases.The oncolytic virus dl922-947 reduces IL-8/CXCL8 and MCP-1/CCL2 expression and impairs angiogenesis and macrophage infiltration in anaplastic thyroid carcinoma.Phase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers.In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf.Genetically Engineered Vaccinia Viruses As Agents for Cancer Treatment, Imaging, and Transgene Delivery.Current status of clinical trials assessing oncolytic virus therapy for urological cancers.The future of immunotherapy for sarcoma.Targeted therapies for the treatment of non-small-cell lung cancer: Monoclonal antibodies and biological inhibitors.Phase I study with ONCOS-102 for the treatment of solid tumors - an evaluation of clinical response and exploratory analyses of immune markers.Intratumoral Delivery of Immunotherapy-Act Locally, Think Globally.Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma.Current Immunotherapeutic Strategies to Enhance Oncolytic Virotherapy.Cowpox Virus: A New and Armed Oncolytic Poxvirus.Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses.Attack of the cancer-killing viruses: clinical application of oncolytic virotherapy in children.Preclinical Testing of an Oncolytic Parvovirus: Standard Protoparvovirus H-1PV Efficiently Induces Osteosarcoma Cell Lysis In Vitro.Recombinant Poxvirus and the Tumor Microenvironment: Oncolysis, Immune Regulation and Immunization.A Comparative Safety Profile Assessment of Oncolytic Virus Therapy Based on Clinical Trials.Tune Up In Situ Autovaccination against Solid Tumors with Oncolytic Viruses.Addressing the Adult Soft Tissue Sarcoma Microenvironment with Intratumoral Immunotherapy
P2860
Q26739777-FBB6C069-2A64-4964-B5BF-7C882770004AQ26747703-0533BB52-FC99-40AE-AB04-AF9A137A1DC4Q28069358-A80CCD74-D3CC-4E55-9CC4-6E34F2B7E28FQ28072347-A7A36D6D-0DAE-4AF8-96B4-08BE9F2B97C7Q30369123-061D6BD6-3260-4C5C-8D4E-89E5DBA788FCQ33625843-F6555FBD-0DE5-47A5-A80F-E6CCF79351D3Q36544212-A533BD3D-B2BA-4E63-9040-B64EDB0DD0E9Q36738884-E41A1A5A-0B9C-498F-8F61-BF89339D9D92Q37256174-CD005022-9FF7-4C4E-B70A-060FEE04E107Q38657642-D1E3E133-79B7-450A-B069-B4BF94E5F192Q38673968-98E2D4A3-E45C-4195-87A6-8A40189347ABQ38741837-E13BB330-B3CD-4038-B0E2-0C21CEB0AB67Q38829558-B1E4434C-FF50-4C8F-A083-8B8D40EE464CQ39004424-ECBE5E05-F4F5-4F2B-83EF-645727A80F75Q39004582-B51FCD98-8A3D-4B94-B8E2-482F50C13A64Q39043844-BF7E77D4-08F0-48D8-A64D-D6298A056E5AQ39358916-EF6C68F8-E004-4436-A28E-EDE4611DD67DQ39387174-F72FD213-5E9E-4107-A80F-D9F32117E4C2Q41689720-5DE7354F-28AA-4078-99E1-0D3BDDBDB8ECQ41919532-F7CF8CE3-3A11-4954-938D-7816F41BE62EQ42170507-C701D01B-3924-4CB1-993E-4564266C3E1AQ47242457-5D71CC36-A0CA-4084-B863-B50A301408C3Q51007512-E8CDAA22-406A-4B83-B20B-EB7279EFA898Q54461045-39F84217-A5EB-45A4-8294-792093172A95Q55509278-1678563C-9E8A-41A3-BD54-F838F5BFF545Q58787920-0BA01E56-266B-4832-9E2D-96E5BE2C0CC2
P2860
Phase 1 study of intratumoral Pexa-Vec (JX-594), an oncolytic and immunotherapeutic vaccinia virus, in pediatric cancer patients.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Phase 1 study of intratumoral ...... in pediatric cancer patients.
@ast
Phase 1 study of intratumoral ...... in pediatric cancer patients.
@en
type
label
Phase 1 study of intratumoral ...... in pediatric cancer patients.
@ast
Phase 1 study of intratumoral ...... in pediatric cancer patients.
@en
prefLabel
Phase 1 study of intratumoral ...... in pediatric cancer patients.
@ast
Phase 1 study of intratumoral ...... in pediatric cancer patients.
@en
P2093
P2860
P356
P1433
P1476
Phase 1 study of intratumoral ...... in pediatric cancer patients.
@en
P2093
Adina Pelusio
Alexander J Towbin
Caroline J Breitbach
Chrystal U Louis
Cliona M Rooney
David H Kirn
James I Geller
James M Burke
John M Racadio
P2860
P304
P356
10.1038/MT.2014.243
P50
P577
2014-12-22T00:00:00Z